Niusule Biotech Corp., a biotech company focused on developing and selling nutritional products for children, has appointed Ping (Vince) Huang as the company's chief financial officer.
Huang’s work experience includes key positions in investment banking, consulting, and business development. He most recently served as an investment consultant for PIEPS, an affiliate of Gemstong Capital, where he initiated and managed qualitative and quantitative analysis for buyout execution.
Huang also worked on the University of Alabama-Birmingham’s life-science entrepreneurship program, where he was responsible for analysis and market research related to the commercialization of intellectual property. Prior to that, Huang was a business analyst for Beijing Kawin Biotech Co., Ltd., coordinating regulatory approvals for manufacturing and control processes.
He holds a Bachelor of Engineering degree with a major in Biopharmaceuticals from China Pharmaceutical University and a Masters of Business Administration specializing in Finance from the UCLA Anderson School of Management. Huang has a Ph.D. in Pharmacology and Toxicology from the University of Alabama, Birmingham. He is fluent in English and Mandarin.